MacroGenics | MGNX - Capital Ordinário

Preço das Ações
2.86
Mudança Diária
-0.04 -1.38%
Mensal
63.43%
Anual
43.36%
Q1 Previsão
2.77




Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Daiichi Sankyo JPY 1.85B 9K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Genmab DKK 61.62M 52K 2025-12
Geron USD 638.36M 338K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
J&J USD 2.41B 584K 2025-09
Karyopharm Therapeutics USD 13K 0 2024-09
MacroGenics USD 63.32M 60K 2025-12
Merck USD 2.49B 15.79M 2025-09
Pfizer USD 5.69B 1000K 2025-09
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Xencor USD 71.87M 529K 2025-12